Transcription of Coverage Rationale Applicable Codes
{{id}} {{{paragraph}}}
Prolotherapy and Platelet Rich Plasma Therapies Page 1 of 24 UnitedHealthcare commercial Medical Policy Effective 01/01/2022 Proprietary Information of UnitedHealthcare. Copyright 2022 United HealthCare Services, Inc. UnitedHealthcare commercial Medica l Policy Prolotherapy and Platelet Rich Plasma Therapies Policy Number: 2022T0498V Effective Date: January 1, 2022 Instructions for Use Table of Contents Page Coverage Rationale .. 1 Applicable Codes .. 1 Description of Services .. 2 Clinical Evidence .. 2 Food and Drug Administration .. 18 References .. 18 Policy History/Revision Information .. 23 Instructions for Use.
Listing of a code in this policy does not imply that the service described by the code is a covered or non- covered health service. Benefit coverage for health services is determined by the member specific benefit plan document and applicable laws that may ... UnitedHealthcare Commercial Medical Policy Effective 01/01/2022 .
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}